Welcome to New World next week.

I'm James Corbett of Corridor Report.com.

And I'm James Evan Polato from MediaMonarchy.com.

We should renew our discussion of adequate deterrence.

We've got that story plus black ops in Nova Scotia.

But first, happening this morning, our first segment on this New World Next Week episode will be a two-parter, the first part, some breaking news.

Bayer settles round-up cancer lawsuits for up to $10.9 billion.

After more than a year of talks, Bayer agreed to pay as much as $10.9 billion. After more than a year of talks, Bayer agreed to pay as much as $10.9 billion with a B

to settle close to 100,000 U.S. lawsuits claiming that it's widely used weed killer

Roundup caused cancer, resolving litigation that has pummeled the company's share price.

The settled cases over Roundup and other

glyphosate-based weed killers account for about 95% of those currently set for trial, but here is,

I think, the sad takeaway on top of just the sadness of all of this. Bear did not admit liability

or wrongdoing, meaning Roundup stays on the shelves. It doesn't have any warnings on it,

and they get the added bonus of now being able to say that all those wild claims were never

proven in a court of law. The deal dwarfs previous out-of-court product liability settlements

by other fantastic groups such as Merck and Company's $5 billion deal to end litigation

over there withdrawn painkiller Vioxx and Bayer deals worth $2 billion to settle claims of harm

caused by its Yasmin birth control pills, James, which I hadn't even actually ever heard of before,

which shows how good they are is, of course, sweeping a lot of this under the rug when, oh, whoops, that product, we warp speed to market,

ended up killing a bunch of people.

The other bit on this part, too, the other bit of gross news from the food world order,

...